News

Filter

Current filters:

Lee's Pharmaceutical

Transgene, Lee’s Pharma and SillaJen confirm clinical development plan for Pexa-Vec

27-03-2014

France’s Transgene, Hong Kong-based Lee’s Pharmaceutical and South Korea’s SillaJen have unveiled…

BayerLee's PharmaceuticalNexavarOncologyPexa-VecPharmaceuticalResearchSillaJenTransgene

Dilafor partners with Lee’s Pharmaceutical for tafoxiparin

24-02-2014

Sweden-based Dilafor AB, a Karolinska Development portfolio company, and Lee’s Pharmaceutical Holdings,…

Asia-PacificChinaDilafor ABKarolinska DevelopmentLee's PharmaceuticalLicensingPharmaceuticalReproductivetafoxiparinWomen's Health

RegeneRx and Lee's Pharma complete license deal for China and Taiwan

17-07-2012

USA-based RegeneRx Biopharmaceuticals (OTC Bulletin Board: RGRX) has entered into a licensing agreement…

Asia-PacificLee's PharmaceuticalLicensingOphthalmicsPharmaceuticalRegeneRxResearchSigma Tau

Back to top